Published in Pharma Law Weekly, December 28th, 2004
The award recognizes Hologic for its work in the detection of breast cancer through tomosynthesis, a new investigational imaging technology.
Tomosynthesis is a 3-D imaging technology that involves the acquisition of multiple images of a stationary compressed breast from different angles during a short scan.
Tomosynthesis is similar to computed tomography (CT), but unlike CT scans which commonly use 360 degree revolutions with less than hundred slices, tomosynthesis uses a smaller, selected number of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.